Carlumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Carlumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target MCP-1
Clinical data
Legal status
?
Identifiers
CAS number 1174395-19-7 N
ATC code None
Chemical data
Formula C6442H9966N1706O2018S40 
Mol. mass 144.88 kDa
 N (what is this?)  (verify)

Carlumab is a human monoclonal antibody designed for oncology and immune indications.[1]

Carlumab was developed by Johnson & Johnson.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Carlumab". American Medical Association.